Tag: Communication Policy

How do researchers and journalists in Brazil relate to each other?

Scientists admit that dealing with complex issues related to their research with journalists is not an easy task. However, long they realized that communicate their results in scientific journals is not enough. To obtain research grants, attract collaboration opportunities and for career advancement, it is necessary – and advisable – to communicate with the public through journalists. Read about the details of this relationship and what can be done to improve it. Read More →

The Open Data movement: international consolidation


The open data movement – the availability of scientific research data for preservation, searching, using and citing – is gaining followers in all sectors of the academic world, and with editors, publishers, research institutions and funding agencies. The movement will allow greater interoperability, transparency, visibility and research impact, in addition to ensuring the digital preservation of the original data that would otherwise have a tendency to be lost or become inaccessible with the passage of time. Read More →

South America science in Nature


The celebrated journal Nature devotes a special section of its June 11 issue to an analysis of South American research output, highlighting areas of excellence and innovation which are internationally recognized, and fields of collaboration with other countries both inside and outside the region. The articles in this section stress the economic and infrastructural inequalities within the region, as well as the low levels of investment in research and development, and point to FAPESP as a successful model of investment directly linked to a state’s GDP. Read More →

The EU will centralize the registry of clinical trials


In April 2014, the European Union approved legislation regulating the registry of clinical trials. This will allow for transnational cooperation between laboratories and institutions of research. The measure will contribute to the transparency and dependability of the trials, and will also allow research into drugs for the treatment of rare diseases. The first registry of clinical trials was created by the WHO in 2004. Currently, registering clinical trials is mandatory in the majority of the countries. Read More →